Results 81 to 90 of about 2,191 (125)

Development and Characterization of a Patient-Derived <i>KIF5B-RET</i> Fusion Lung Adenocarcinoma Cell Line for Subcutaneous and Central Nervous System Tumor Models in Immunodeficient Mice. [PDF]

JTO Clin Res Rep
Nishiyama A, Sato S, Sakaguchi H, Kotani H, Yamashita K, Ohtsubo K, Nanjo S, Yano S, Mizuguchi K, Ikeda H, Yamaguchi M, Ishizuka T, Baba S, Takeuchi K, Takeuchi S.   +14 more
europepmc   +1 more source

Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinoma. [PDF]

Cancer Lett
Hinz TK, Le AT, Doan T, Ast A, Jaramillo S, Avila JT, Skhisov D, Haines S, Navarro AC, Patil T, Nemenoff RA, Heasley LE.   +11 more
europepmc   +1 more source

Generation of a distal lung cancer organoid model using oncogenic ret-expressing induced pluripotent stem cells. [PDF]

iScience
Hwang JW, Desterke C, Marcoux P, Bani MA, Griscelli F, Bennaceur-Griscelli A, Turhan AG.   +6 more
europepmc   +1 more source

Targeted therapy combined with local consolidative surgery for oligometastatic stage IVA lung adenocarcinoma with CCDC6-RET fusion: a case report. [PDF]

Front Oncol
Gao F, Fan Y, Fan Q, Mei T, Khan MQ, Zhou A, Liu H, Dong J.   +7 more
europepmc   +1 more source

Identification of a Novel <i>GOLGB1-RET</i> Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib. [PDF]

JCO Precis Oncol
Boku S, Fujisawa T, Kadowaki S, Satake H, Yasui H, Ohtsubo K, Shimizu Y, Otsuka T, Kuze B, Yamashita R, Shibuki T, Nakamura Y, Bando H, Yoshino T, Radovich M, Okano S.   +15 more
europepmc   +1 more source

How to manage medullary thyroid carcinoma: current treatment strategies. [PDF]

Drugs Context
Saltiki K, Karapanou O, Michalaki M, Effraimidis G.   +3 more
europepmc   +1 more source

Efficacy of selpercatinib as a first-line treatment for <i>RET</i>-fusion positive non-small-cell lung cancer: a novel two-stage Bayesian network meta-analysis. [PDF]

J Comp Eff Res
Forsyth JE, Khanal M, Kiiskinen U, Jyothi A, Goel R, Puri T, Ren S, Sonksen MD, Wang X, Jen MH.   +9 more
europepmc   +1 more source

Management of ectopic Cushing syndrome in medullary thyroid carcinoma: from case reports to systematic literature review. [PDF]

Front Endocrinol (Lausanne)
Stanescu LS, Ioachim D, Muresan A, Smarandache R, Lider-Burciulescu SM, Gheorghiu ML, Badiu C.   +6 more
europepmc   +1 more source

Safety and effectiveness of selpercatinib in patients with RET fusion-positive non-small cell lung cancer in real-world clinical practice: a postmarketing study in Japan. [PDF]

Jpn J Clin Oncol
Chen Y, Mori J, Wakabayashi S, Urayama KY.   +3 more
europepmc   +1 more source

An Uncommon Presentation of Selpercatinib (Retevmo)-Induced Severe Transaminitis: A Biopsy-Proven Case Report. [PDF]

Cureus
Biswas N, Dudhia K.
europepmc   +1 more source